Table 3.
Parameter | Value |
Source | ||
---|---|---|---|---|
Erasmus MC |
Warwick | |||
Model E0 | Model E1 | Model W | ||
Birth rate (per 1000/yr) | Bihar specific | District-specific (see SF2) | Indian 2011 Census | |
Mortality rate (per 1000/yr) | Bihar specific, age-dependent |
District-specific (see SF2) | Indian 2011 Census | |
Sandfly birth rate | Stepwise function with 3 month peak in July–Sept | Sinusoidal function with peak in Oct–Nov | (Poché et al., 2011) (E0, E1) (Picado et al., 2010b, Kesari et al., 2014, Ghosh et al., 1999) (W) | |
Infectivity of PKDL, relative to symptomatic untreated cases | 0.5 | 0.5 | N/A | Expert opinion |
Duration of immunity (years) | 2 (1 and 5 in sensitivity analysis) | 2 (1 and 5 in sensitivity analysis) | 5 | Assumption based on (Le Rutte et al., 2016) (E0,E1) Assumption based on (Chapman et al., 2015) (W) |
Average duration of PKDL (years) | 5 | 5 | N/A | Expert opinion, (Ramesh et al., 2015) |
Sandfly exposure | Age-dependent | Age-dependent | N/A | (Le Rutte et al., 2016) |
Duration of early asymptomatic stage (days) | 202 | 202 | Early + late = 150 | (Le Rutte et al., 2016) (E0, E1) (Chapman et al., 2015) (W) |
Duration of late asymptomatic stage (days) | 69 days (fitted) | 69 days (fitted) | ||
Infectivity of asymptomatic stage | 0 (pre-set) | 0.0114 (early) 0.0229 (late) (fitted) | 0.025 | Assumption based on (Stauch et al., 2011) (W) |
Fraction of (late stage) asymptomatic individuals who develop VL | 0.0142 (fitted) | 0.0142 (fitted) | 0.03 | Assumption based on (Hasker et al., 2014) (W) |